Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design

I. Vaxman, S. K. Kumar, F. Buadi, M. Q. Lacy, D. Dingli, Y. Hwa, A. Fonder, M. Hobbs, S. Hayman, T. Kourelis, R. Warsame, E. Muchtar, N. Leung, P. Kapoor, M. Grogan, R. Go, Y. Lin, W. Gonsalves, M. Siddiqui, R. A. KyleS. V. Rajkumar, M. A. Gertz, A. Dispenzieri*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)3604-3607
Number of pages4
Issue number12
StatePublished - Dec 2021


FundersFunder number
Predolin Foundation
National Cancer InstituteP50CA186781
Jabbs Foundation

    Cite this